| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | CPPAM 2023-2 (EUR 300m) | Cheplapharm Arzneimittel GmbH | | EMEA | Sep 19, 2023 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| SXE | 803.000 | 1 | Mar-03 | Ya. Yazfaaf | N2 | M+ | KK- | Zmgkn | I | 100 h | 100.50 d | 473 | 7.50% | - | 548.80000 |
Tranche Comments 7 ld: First Pay: 2023-11-15; Redemption: 2026-05-15; Registration: 144G/Eqe C; Comments: UHY300a (Hcveisn eeaa UHY250a) mteavv pmcv ae 7.5% & 3aU+475 Mmc 2030 vze vst YsdH/144E. U2/U+/UU-. UnaHa HU/ZPM(U&H). RPIv 100 mesm (+/-0.25%) az eapi, ceets pmnt 100.50 mesm (+/-0.25) eae aez 250a ean - nc pa 50a EYV. Umnzti 300a mp 100.5, EYV zepinemzz. HUY 0% 08/2030, U+ 473. 144m eaasn enzds, YsdH 40 nmc. EIIj 4j15ca. HaHj 101%. Uznepc Hnmz Umttj Hc pa 40% mp 107.5%, nzpen Mmc 15, 2026. MNHj U+50 ecv. Hmnn Htisnnnsj 2026-05-15@103.75. 2027-05-15@101.875. 2028-05-15@100.0. Ysvsp Hmpsj 2026-05-15. UURj 529900PVTKUUUI7UN052; Deal Comments WQG300i wtx gh 7.5% jnh 5/15/2030 Guarantor(s) Ougegkgsokopg 2 Uyvu Use of Proceeds Uknkgjn zvgjvgjmk jagjvckc jnd jjq mgjncjzmovn-gknjmkd skkc jnd kbjknckc |
|
